CFR Pharmaceuticals Makes $1.3 Billion Cash and Share Offer for Adcock Ingram

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Adcock Ingram Holdings Ltd. (AIP) said it received a non-binding bid from Chilean drugmaker CFR (CFR) Pharmaceuticals SA that values South Africa’s largest supplier of hospital products at 12.9 billion rand ($1.3 billion).

The potential offer price from CFR is 73.51 rand, 14 percent more than Adcock’s closing price of 64.50 rand yesterday, Johannesburg-based Adcock said in a statement today. CFR would pay in cash and stock, the South African company said.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC